ALK-Abelló
Logotype for ALK-Abelló

ALK-Abelló (ALK) investor relations material

ALK-Abelló Q4 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for ALK-Abelló
Q4 2025 earnings summary20 Feb, 2026

Executive summary

  • Achieved strong Q4 and full-year 2025 results at the top end of guidance, with significant commercial and financial milestones driven by tablet and anaphylaxis product growth.

  • Expanded pediatric indications for key allergy tablets, broadening patient reach and prescriber base, especially in Europe and North America.

  • Successful European rollout of neffy, with 18% value share in Germany and launches in several new markets, plus co-promotion in the USA and regulatory review in Canada.

  • Reached the '25in25' milestone, treating 3.1 million patients, an increase of 0.5 million year-over-year.

  • Strategic growth investments and strengthened partnerships in China, Japan, and the U.S. supported expansion and future growth.

Financial highlights

  • Revenue grew 15% year-over-year to DKK 6,312 million ($1 billion), with double-digit growth in all regions and tablets/anaphylaxis as key drivers.

  • EBIT margin reached 26% for 2025, up from 20% in 2024, with EBIT up 53% and margin surpassing the 25% target.

  • Gross profit increased to DKK 4,234 million, gross margin up 3 points to 67% due to higher sales and efficiencies.

  • Free cash flow positive at DKK 1,432 million, compared to -DKK 204 million in 2024, reflecting higher earnings and upfront payments.

  • Dividend of DKK 355 million proposed, 30% of net profit after tax.

Outlook and guidance

  • 2026 revenue expected to grow 11%-15% in local currencies, with EBIT margin around 25%.

  • Growth to be volume-driven across all regions and product groups; tablet and anaphylaxis sales to grow double digits, SCIT/SLIT-drops single digits.

  • Gross margin expected to decrease slightly due to product mix and higher partner-related sales; continued investment in R&D and infrastructure.

  • Free cash flow projected at DKK 800 million–1 billion; CapEx around DKK 500 million, with R&D costs at ~10% of revenue.

Neffy Germany value vs. volume share dynamics?
Peanut tablet US market strategy vs. respiratory?
New R&D Head profile and strategic focus?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next ALK-Abelló earnings date

Logotype for ALK-Abelló
Q4 202523 Feb, 2026
ALK-Abelló
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next ALK-Abelló earnings date

Logotype for ALK-Abelló
Q4 202523 Feb, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. The company produces test kits for allergy and asthma assessment; allergy alert systems; blood pressure monitors; clinical chemistry analyzers; immunoassays and biochemistry instruments, Bruker X-ray fluorescence spectrometers, and various other products. It also provides allergy diagnostic solutions, including skin testing systems; test kits to identify urushiols that cause natural rubber allergies; laboratory equipment to measure patient serum samples suspected of having restricted proteins; a compact EDM device that helps dermatologists treat contact dermatitis via electromagnetic healing vibrations; a patch test panel to help prevent hospital patients from developing hypersensitivity and subsequent allergies during their stay; a test kit for the identification of contact urticaria triggered by nickel based alloys used in jewellery making and dental implants.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage